Madrigal Pharmaceuticals
Buying intent
49 tracked signals | Top 15 topics are below | Engineering and HR are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Madrigal Pharmaceuticals's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
10d ago
15d ago
19d ago
19d ago
17d ago
19d ago
10d ago
13d ago
20d ago
22d ago
15d ago
19d ago
17d ago
19d ago
25d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Madrigal Pharmaceuticals
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
18 people across every department at Madrigal Pharmaceuticals, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileMadrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), a serious form of fatty liver disease. Left untreated, MASH can lead to progressive liver scarring, cirrhosis, liver failure, liver cancer, need for transplant and premature mortality. Our goal is to hal
New capability sought
Employee posts (LinkedIn)Pharmaceutical; Thought Leadership; Conference; Healthcare Professionals; Patient Advocate
Top accounts researching Madrigal Pharmaceuticals
names withheld on the public pageThese are companies whose own people brought up Madrigal Pharmaceuticals unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
75,708 companies · 411,263 people are researching Hiring
Madrigal Pharmaceuticals's own team shows 7 signals on this topic. No one outside Madrigal Pharmaceuticals has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Patient Advocacy600 cos · 1,813 people
- Healthcare Providers4,337 cos · 17,664 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Leadership — 3 people; Marketing — 2 people; HR / Talent — 1 person; Engineering — 1 person; Sales — 1 person
What's been said
public posts by Madrigal Pharmaceuticals's teamNo public post naming Madrigal Pharmaceuticals has surfaced in the past year, so this is what Madrigal Pharmaceuticals's own team is posting about publicly — their topics, in their words.
Madrigal AI team representing at #LangchainInterrupt with Parth Patel, PhD, MS Max Bertolero and Jose Zamalloa
May 2026Exciting night with fellow HR colleagues who shared the same aspirations for industry at large, our function, and our respective companies. The main topic was around AI. While most organizations can now put AI tools in front of their people, far fewer have figured out how to build the judgment to use them well. Most think it is IT issue but in reality, it's a human development one and that means it falls squarely in HR's lane to bring people along without leaving them behind. No clear answers yet, but the right people are asking the right questions.
May 2026Diving into the frontier of Agentic AI at Interrupt 2026 LangChain with our team! 🚀 Two packed days of real-world lessons from engineering teams at companies like Cisco, Toyota, Lyft, and Coinbase, all focused on what it actually takes to build and ship agents at enterprise scale. Huge inspiration to bring back to our own work. Say hi if you’re around! #AI #AgenticAI #LangChain #Interrupt2026
May 2026A lot of people ask me how my neuroscience background applies to my AI work. Tom Griffiths has some great insights here that people in AI will enjoy.
May 2026Strategic priorities
Earnings call; SEC filingsStrategic Growth; Double Digit; InMarket
What changed recently
Earnings call; SEC filingsStrategic Growth; Double Digit; InMarket